Abstract
Background Current guidelines recommend reversal of warfarin anticoagulation with intracranial hemorrhages. The benefit of reversing subtherapeutic warfarin anticoagulation in acute spontaneous intracerebral hemorrhage (ICH) is uncertain.
Methods An observational cohort used Get With The Guidelines® Stroke registry between January 2015 and January 2022 to determine association of reversal with outcomes for subtherapeutic anticoagulation (INR 1.5 to 1.9). Exclusions were thrombolytics, direct oral anticoagulants, transferring out, or leaving against medical advice.
Results The primary outcome (mRS 0-3 at discharge) was assessed among 1868 patients (mean age 73 years, 42% female), which occurred in 188/894 (21.0%) with reversal and 225/974 (23.1%) without reversal (adjusted odds ratio (aOR) 0.80 [95% CI 0.63-1.005]). Ordinal analysis showed higher odds of mRS 0-4 vs. 5-6 with reversal {52.7% vs 42.5% (aOR 1.21 [1.001, 1.48])}. Outcomes not requiring mRS were analyzed among 2569 patients. Mortality or discharge to hospice was lower with reversal {30.6% vs 41.5% (aOR 0.75 [95% CI, 0.63, 0.89])}. Fewer were ambulatory at discharge {25.8% vs 35.7% (aOR 0.68 [0.54, 0.85])}, fewer discharged to home {18.4% vs 21.7% (aOR 0.79 [0.65, 0.97])}, more discharged to skilled nursing {21.0% vs 15.7% (aOR 1.33 [1.08, 1.65])}, and more discharged to rehabilitation {24.9% vs 18.9% (aOR 1.20 [0.98, 1.47])}. Hospital length of stay was longer {median 6 vs 4 days (adjusted risk ratio (aRR) 1.25 [95% CI, 1.13, 1.37]). There was no difference in venous thromboembolism {2.9% vs 2.3% (aOR 1.47 [0.88, 2.46])}.
Discussion Reversal of subtherapeutic warfarin with acute spontaneous intracerebral hemorrhage and INR 1.5 - 1.9 was not associated with improvement in functional outcome based upon discharge mRS 0-3 vs 4-6. Patients that received a reversal agent had 25% lower odds of dying in the hospital or being discharged to hospice, but had a longer hospital stay and were less likely to be fully ambulatory at discharge.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Get With the Guidelines® Stroke (GWTG) program is provide by the American Heart Association/American Stroke Association. GWTG Stroke is sponsored, in part, by Novartis, Novo Nordisk, AstraZeneca, Bayer, Tylenol, Alexion, and AstraZeneca Rare Disease.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
DCRI IRB approval
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The GWTG-Stroke database has independent policies for use of data.
Abbreviations
- aOR
- adjusted odds ratio
- aRR
- adjusted risk ratio
- BMI
- body mass index
- BP
- blood pressure
- CI
- confidence interval
- CMO
- comfort measures only
- DOAC
- direct oral anticoagulant
- DVT
- deep venous thrombosis
- EMS
- emergency medical services
- FUNC
- Functional outcome in patients with primary intracerebral hemorrhage score
- GCS
- Glascow coma scale
- GWTG
- Get With The Guidelines
- GWTG-Stroke
- Get With The Guidelines – Stroke
- ICH
- intracerebral hemorrhage
- INR
- international normalized ratio
- LOC
- level of consciousness
- LOS
- length of stay
- mRS
- modified Rankin scale
- NIHSS
- NIH stroke scale
- OR
- odds ratio
- PE
- pulmonary embolus
- SD
- standard deviation
